However, it has been demonstrated that a robust neutralizing antibodies response is sufficient to prevent lethal infection after both peripheral and intracranial challenge with WNV NY99 regardless of the presence of CD8+ T cells [19]. The gene discussed is CD8A; the disease is infection.